Knoll Capital Management as of June 30, 2013
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 11 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 84.3 | $123M | 2.5M | 49.20 | |
| Ampio Pharmaceuticals | 5.2 | $7.5M | 1.3M | 5.77 | |
| Alcobra | 2.8 | $4.0M | 587k | 6.85 | |
| Sequenom | 2.7 | $3.9M | 928k | 4.21 | |
| Genworth Financial (GNW) | 2.5 | $3.7M | 320k | 11.41 | |
| Vivus Inc option | 1.0 | $1.4M | 5.0k | 286.00 | |
| Newlink Genetics Corporation | 0.6 | $935k | 47k | 19.71 | |
| Keryx Biopharmaceuticals | 0.5 | $747k | 100k | 7.47 | |
| Achillion Pharmaceuticals | 0.3 | $450k | 55k | 8.18 | |
| Celgene Corporation | 0.1 | $204k | 28k | 7.31 | |
| Echo Therapeutics | 0.1 | $111k | 444k | 0.25 |
